Stanford Cancer Institute




Cancer News

  • May 22, 2024
     | Stanford Cancer Institute

    Engineered CD47 protects T cells for enhanced antitumor immunity

    Stanford scientists illuminate the relationship between adoptively transferred T cells and macrophages and how two immunotherapies may work together to increase their tumor-fighting capabilities.
  • May 10, 2024
     | Stanford Cancer Institute

    Cancer clinical trials launched at Stanford clinic in Emeryville

    The first cancer clinical trial was launched at the Stanford cancer clinic in Emeryville.
  • May 9, 2024
     | Stanford Cancer Institute

    20th anniversary of the Stanford Cancer Institute

    The Stanford Cancer Institute celebrates its 20th anniversary.
  • May 7, 2024
     | Stanford Cancer Institute

    The promise of TIL therapy

    Thanks to the partnership with Stanford’s Advanced Melanoma Program and Blood and Marrow Transplantation (BMT) & Cellular Therapy Program, Stanford treated the first patient in the world with the newly approved TIL therapy. 
  • May 6, 2024
     | News Center

    Cell-based therapy for solid tumors

    The FDA recently approved the first cell-based therapy — widely used in treating blood cancers — for solid tumors. Stanford Medicine treated the first patient with advanced melanoma.
  • April 23, 2024
     | Stanford Cancer Institute

    Radiotherapeutic advances in lung cancer treatment

    Within the past couple of decades, the field of oncology has witnessed a shift to more curative treatments for patients with lung cancer, with radiation being a key factor in this new trajectory.
  • April 15, 2024
     | Stanford Cancer Institute

    Stanford scientists and Children’s Hospital of Philadelphia identify protein that controls CAR-T cell longevity

    Cancer scientists at Stanford and the Children’s Hospital of Philadelphia (CHOP) identified a protein, FOXO1, that improves the survival and function of CAR-T cells, which may lead to more effective CAR-T cell therapies and could potentially expand...
  • Woman, face and skincare science with overlay on mockup space in hygiene, dermatology or cosmetics. Futuristic person, model and scientific technology in cosmetology, beauty makeup or facial genetics.
    April 11, 2024
     | News Center

    AI advice helps skin cancer diagnoses

    Artificial intelligence algorithms powered by deep learning improve skin cancer diagnostic accuracy for doctors, nurse practitioners and medical students in a study led by the Stanford Center for Digital Health.
  • April 10, 2024
     | News Center

    Virtual biopsy shows promise

    Stanford Medicine researchers develop a new imaging method to create a cell-by-cell reconstruction of skin or other tissue without taking a biopsy.
  • April 9, 2024
     | Stanford Cancer Institute

    Supporting adolescent and young adult cancer patients

    The Stanford Adolescent and Young Adult Cancer program supports this age group's unique challenges.
  • March 26, 2024
     | News Center

    AI tools take on soft tissue sarcomas

    Soft tissue sarcomas are rare and difficult to treat. Machine-learning tools designed at Stanford Medicine uncover distinct cellular communities that correlate with prognosis, immunotherapy success.
  • March 1, 2024
     | Stanford Cancer Institute

    Navigating cancer care with the Stanford Care Coach Program

    To help facilitate advanced care planning, Stanford Cancer Care Services implemented the Care Coach Program based on data-driven research.
  • March 1, 2024
     | Stanford Cancer Institute

    ASH president-elect: A look back on the path that led him here

    In 2023, Negrin was elected president of the American Society of Hematology (ASH) after over 25 years of service to the organization.
  • February 1, 2024
     | Stanford Cancer Institute

    2024 Tandem Meetings | Transplantation & Cellular Therapy Meeting of ASTCT and CIBMTR

    Stanford has 10 presenters at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meeting of ASTCT and CIBMTR.
  • February 1, 2024
     | Stanford Cancer Institute

    World Cancer Day: Stanford cancer researchers drive progress in closing the care gap

    In honor of the 2024 World Cancer Day theme, “Close the Care Gap,” we highlight a few Stanford cancer researchers working to close the care gap in diverse populations through screening, clinical trials, prevention, and community engagement.
  • February 1, 2024
     | Stanford Cancer Institute

    The Stanford Cancer Institute Early Drug Development program awarded for increasing clinical trial access

    The Stanford Cancer Institute Early Drug Development (EDD) program brings in early-phase clinical trials so cancer patients can have access to innovative treatments that could provide a therapeutic benefit.
  • February 1, 2024
     | Stanford Cancer Institute

    CAR-T cell therapy in solid tumors

    CAR-T therapy has shown a great benefit in patients with hematologic and lymphatic cancers. However, applying the therapy to solid tumors has proven to be challenging. One of the barriers is T cell exhaustion, where the CAR-T cell becomes...
  • February 1, 2024
     | Stanford Cancer Institute

    Stanford cancer patient story: Meryl Selig

    Meryl Selig has had a unique experience at the Stanford Cancer Institute (SCI). She began as a patient volunteer in 2009 before being diagnosed with cancer and becoming a patient. She became one of the first patients to receive a novel chimeric...
  • February 1, 2024
     | News Center

    New guidelines suggested for liver cancer

    A Stanford Medicine study identifies an easily measured biophysical property that can identify Type 2 diabetics at increased risk for liver cancer who don’t meet current screening guidelines.
  • Untitled Artwork
    January 17, 2024
     | News Center

    Screening, treatment halve breast cancer deaths

    Treatment of metastatic disease is responsible for nearly one-third of the decrease in annual deaths from breast cancer from 1975 to 2019, according to a Stanford Medicine-led study.
  • January 1, 2024
     | Stanford Cancer Institute

    Tumor boards improve outcomes

    The Stanford Cancer Institute has over a dozen tumor boards dedicated to identifying each patient's most effective cancer treatment and care strategy.
  • Female Reproductive System
    January 1, 2024
     | Stanford Cancer Institute

    Navigating challenges in cervical cancer brachytherapy with TARGIT-FX

    Stanford Cancer Institute member Elizabeth Kidd, MD, is developing new tools to facilitate the broader adoption of brachytherapy and ultimately improve outcomes for women facing cervical cancer.
  • December 11, 2023
     | News Center

    Tumor DNA levels in blood predict outcome

    Circulating tumor DNA predicts recurrence and splits disease into two subgroups in Stanford Medicine-led study of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity.
  • Untitled design - 1
    December 2, 2023
     | Stanford Cancer Institute

    Lung cancer survivors who have never smoked have a high risk of developing new cancers

    A study led by SCI members Summer Han, PhD, and Eunji Choi, PhD, and graduate student Chloe Su found that lung cancer survivors who have never smoked have the same risk as survivors who have smoked of developing secondary primary lung cancer (SPLC),...
  • December 2, 2023
     | Stanford Cancer Institute

    Protecting the rights of cancer patients

    On August 30, 2021, California adopted the Cancer Patients’ Bill of Rights, the first legislation of its kind in the United States. This legislation gives cancer patients inalienable rights to help them achieve access and equity in their care.
  • November 22, 2023
     | News Center

    Scar tissue predicts lifespan

    Pancreatic cancer is deadly, and its toll is growing. Scientists find that scar tissue around the tumor suggests how long a patient will live after diagnosis.
  • Untitled design - 1
    November 10, 2023
     | Stanford Cancer Institute

    2023 American Society of Hematology Annual Meeting & Exposition

    Stanford is excited to have 26 presenters at this year's ASH Annual Meeting & Exposition. The Stanford Cancer Institute will also be hosting a booth at this year's conference.
  • November 2, 2023
     | Stanford Cancer Institute

    Gastrointestinal cancer: A conversation with George Poultsides, MD

    During Gastric and Pancreatic Cancer Awareness Month, SCI member George Poultsides discusses his efforts to advance early detection of pancreatic cancer, improve personalized oncology, and direct Stanford's Surgical Oncology Fellowship program while...
  • November 1, 2023
     | News Center

    Cancer neuroscience discoveries give hope

    To drive their growth, many tumors hijack nervous system signals, including those needed for brain plasticity. Stanford Medicine discoveries are opening a promising new branch of oncology research.
  • November 1, 2023
     | Stanford Cancer Institute

    Innovating the early detection of pancreatic cancer

    Stanford Cancer Institute members Ash Alizadeh, MD, PhD, and Max Diehn, MD, PhD, have developed several novel techniques for early detection of cancer that rely on blood-based liquid biopsies.
  • CT scan (computed tomography) of chest, coronal view, showing pulmonary metastasis, lung cancer
    October 26, 2023
     | News Center

    African Americans less likely to be screened

    National guidelines for lung cancer screening are less effective for African Americans than for whites, Stanford study concludes. A risk-based analysis is more equitable and effective.
  • ImageJ=1.52q
unit=\u00B5m
    October 23, 2023
     | News Center

    Lung cancer cells protected by brain cells

    Small cell lung cancers often metastasize to the brain. A Stanford Medicine study shows they thrive there by emulating developing neurons and recruiting surrounding cells for protection.
  • 3d illustration of immune system T cells attacking cancer cells (CAR T-cell therapy)
    October 3, 2023
     | News Center

    Reena Thomas gets $12 million CIRM grant

    The award will facilitate a clinical trial testing the safety of CAR-T cells — immune cells from patients’ own bodies that have been bioengineered to destroy cancer cells — used to treat a deadly brain cancer.
  • October 2, 2023
     | Stanford Cancer Institute

    Meeting Unmet Needs in Breast Cancer

    We spoke with Stanford Cancer Institute (SCI) leaders to learn about advances in breast cancer treatment, issues affecting survivors, and bridging the racial inequities gap.
  • October 1, 2023
     | Stanford Cancer Institute

    CAR-T Cells and Cancer Therapeutics

    The overarching goal of the Cancer Therapeutics Program is to foster collaboration across scientific and clinical disciplines in order to gain deeper insights into cancer’s underlying causes and develop more effective diagnostic, prognostic, and...
  • Untitled design - 1
    September 27, 2023
     | Stanford Cancer Institute

    Stanford Presenters at the 2023 ASTRO Conference

    Stanford is excited to have 17 presenters at this year's ASTRO Annual Meeting.
  • September 20, 2023
     | News Center

    Arc Institute awards

    Two professors are named Innovation Investigators, and four win Ignite Awards.
  • September 12, 2023
     | News Center

    Big Ideas in Medicine

    Physicians, researchers and other pacesetters describe some of the most promising pursuits in the medical field. In cancer, for instance: ‘Let’s kill the first cell, not the last cell.’
  • September 2, 2023
     | Stanford Cancer Institute

    Pediatric Leukemia: Elevating the Standard of Care

    To learn more about how Stanford approaches pediatric leukemia, we spoke with Stanford Cancer Institute leader Tanja Gruber, MD.
  • September 1, 2023
     | Stanford Cancer Institute

    SCI Breast Cancer and African Americans Conference Returns In-person

    Over 300 people attended the 12th Annual Conference: SCI Breast Cancer and African Americans on Saturday, August 26 in Newark, CA.
  • September 1, 2023
     | Stanford Cancer Institute

    Stanford joins multi-institutional team developing pioneering immunotherapy technology

    Stanford is excited to have 26 presenters at this year's ASH Annual Meeting & Exposition. The Stanford Cancer Institute will also be hosting a booth at this year's conference.
  • September 1, 2023
     | Stanford Cancer Institute

    Advanced Melanoma Program: Honoring a Legacy

    Recognizing the urgent unmet need for treating patients battling advanced melanoma, the Stanford Cancer Institute (SCI) is establishing the Stanford Advanced Melanoma Program—a world-class advanced melanoma center of excellence on the West Coast.
  • September 1, 2023
     | Stanford Cancer Institute

    SCI Member Spotlight: Marvin Langston, PhD

    SCI member Marvin Langston, PhD, was recently named a member of the inaugural cohort of Cancer Moonshot Scholars, which is part of the Biden Cancer Moonshot initiative. We spoke with him to learn more about his project that will be funded by the...
  • August 24, 2023
     | News Center

    Real-time targeting of tumors

    New technology combines radiotherapy with real-time detection of cancer cells to target moving tumors or multiple metastases. Stanford Medicine is the first to research the technology in the clinic.
  • Collage - 2
    August 22, 2023
     | News Center

    AI could inform brain cancer prognosis

    Stanford Medicine scientists and colleagues create an algorithm that could help physicians better understand and target complicated brain tumors.
  • Phogomicrograph of fine needle aspiration (FNA) cytology of a pulmonary (lung) nodule showing adenocarcinoma, a type of non small cell carcinoma.
    August 8, 2023
     | News Center

    Tumor suppressor repairs tissue

    The tumor suppressor p53 has been in the limelight for decades. But its cancer-fighting function may be only a side effect of its role in tissue repair, a Stanford Medicine study finds.
  • August 2, 2023
     | Stanford Cancer Institute

    Optimizing Lung Cancer Screening With Risk-Prediction Models

    An article published recently in the Journal of Clinical Oncology presented a case study to highlight the value of using risk-prediction models as tools for patient-clinician communication on lung cancer screening.
  • August 1, 2023
     | Stanford Cancer Institute

    Recap of the SCI Pilot Undergraduate Summer Program

    The program provides mentorship from SCI faculty members and hands-on lab experience for Stanford undergraduates interested in exploring cancer-related career tracks.
  • August 1, 2023
     | Stanford Cancer Institute

    Advancements in Sarcoma Research and Treatment

    The Asian Liver Center continues to uphold its pledge to address the disproportionately high rates of chronic hepatitis B infection and liver cancer in Asians and Asian Americans through community outreach, academic studies, and clinical expansion.
  • August 1, 2023
     | Stanford Cancer Institute

    Stanford Cancer Institute Hosts Scholars From Historically Black Medical Colleges in Summer Research Program

    The Stanford Cancer Institute hosted five scholars from Howard University and Morehouse College in a summer research program for medical students from Historically Black Medical Colleges.

Other News

lag 3 protein
March 11, 2024

This protein pic could help develop new cancer treatments | Stanford News

A molecular “snapshot” of a protein can be critical to understanding its function. Scientists at Stanford and NYU have published and investigated a new structure of the protein LAG-3 which could enable the development of new cancer treatments.

RNA  protein
February 21, 2024

A new RNA editing tool could enhance cancer treatment | Stanford News

The new study found that an RNA-targeting CRISPR platform could tune immune cell metabolism without permanent genetic changes, potentially unveiling a relatively low-risk way to upgrade existing cell therapies for cancer.

Media Relations

The Office of Communication & Public Affairs is dedicated to sharing School of Medicine news with the media and helping journalists secure expert interviews, photographs and rich media for stories on medicine and health care.